Sodium Chloride 0.9% Inj 900mg/100ml USP (2018-05-11)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| W8A17C1, W8B02C1, W8B09C1, W8C01C1, W8C01C1F, W8A19C1, W8A25C1, W8A29C1, W8B05C1, W8B05C1S, W8B13C1, W8B21C1, W8B26C1, W8C08C1, W8D13C1 | Sodium Chloride 0.9% Inj 900mg/100ml USP | - Recalling Firm
- Baxter Corporation
- 7125 Mississauga Road
- Mississauga
- L5N 0C2
- CANADA
- Marketing Authorization Holder
- Baxter Corporation
- 7125 Mississauga Road
- Mississauga
- L5N 0C2
- CANADA
| Liquid | DIN 00060208 | SODIUM CHLORIDE 900 MG / 100 ML |
Recalled Products
Sodium Chloride 0.9% Inj 900mg/100ml USP
Potential for leakage of the intravenous bag.
Wholesalers; Healthcare Establishments